*Purpose: Living-donor kidney transplantation is the gold standard treatment for the end-stage renal disease. However, living donors worldwide face significant financial and logistic barriers. To remove these disincentives to living donations, the governments of many countries have implemented reimbursement programs which shifts the burdens of non-medical financial and other costs from the donors to the governments or to the private entities as par by policies permit to encourage the donors to donate their living organs. This study investigate whether these reimbursement programs designed to ease the financial and logistic barriers have been effective to increase the number of living donations worldwide. The study examined cross-country and within-country variation in the timing of such reimbursement programs to analyze their impacts on the number of living organ donations.

*Methods: The study used negative binomial regressions to estimate the effects of these reimbursement programs on a panel data set from 2000 to 2016 for 116 economies where living organ donations are practiced. Both bivariate and multivariate analyses were performed to investigate the effectiveness of the policy with and without adjusting for possible covariates.

*Results: Overall, the result demonstrated the significant positive effect of these reimbursement programs on the number of donations. However, the further analysis indicated that the impact was significant only in high and medium income economy. For the low-income economy, the effect was insignificant presumably due to the small number of countries in this category having any reimbursement program.

*Conclusions: The result in this paper can be a supportive evidence for the policy-makers whether to expand the reimbursement program to minimize the organ shortage.

« Back to 2019 American Transplant Congress